Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MULTIPLE SCLEROSIS - CEREBROSPINAL FLUID , . Treffer: 9

2017

Hennes, EM; Baumann, M; Schanda, K; Anlar, B; Bajer-Kornek, B; Blaschek, A; Brantner-Inthaler, S; Diepold, K; Eisenkölbl, A; Gotwald, T; Kuchukhidze, G; Gruber-Sedlmayr, U; Häusler, M; Höftberger, R; Karenfort, M; Klein, A; Koch, J; Kraus, V; Lechner, C; Leiz, S; Leypoldt, F; Mader, S; Marquard, K; Poggenburg, I; Pohl, D; Pritsch, M; Raucherzauner, M; Schimmel, M; Thiels, C; Tibussek, D; Vieker, S; Zeches, C; Berger, T; Reindl, M; Rostásy, K; BIOMARKER Study Group Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Neurology. 2017; 89(9):900-908
Web of Science PubMed FullText FullText_MUG

 

2013

Pilz, G; Harrer, A; Wipfler, P; Oppermann, K; Sellner, J; Fazekas, F; Trinka, E; Kraus, J Tumefactive MS lesions under fingolimod: a case report and literature review.
Neurology. 2013; 81(19):1654-1658 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Teunissen, C; Menge, T; Altintas, A; Álvarez-Cermeño, JC; Bertolotto, A; Berven, FS; Brundin, L; Comabella, M; Degn, M; Deisenhammer, F; Fazekas, F; Franciotta, D; Frederiksen, JL; Galimberti, D; Gnanapavan, S; Hegen, H; Hemmer, B; Hintzen, R; Hughes, S; Iacobaeus, E; Kroksveen, AC; Kuhle, J; Richert, J; Tumani, H; Villar, LM; Drulovic, J; Dujmovic, I; Khalil, M; Bartos, A Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Mult Scler. 2013; 19(13):1802-1809
Web of Science PubMed FullText FullText_MUG

 

2012

Gonzalo, H; Brieva, L; Tatzber, F; Jové, M; Cacabelos, D; Cassanyé, A; Lanau-Angulo, L; Boada, J; Serrano, JC; González, C; Hernández, L; Peralta, S; Pamplona, R; Portero-Otin, M Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism.
J Neurochem. 2012; 123(4): 622-634. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Teunissen, CE; Khalil, M Neurofilaments as biomarkers in multiple sclerosis.
Mult Scler. 2012; 18(5):552-556
Web of Science PubMed FullText FullText_MUG

 

2010

Sargsyan, SA; Shearer, AJ; Ritchie, AM; Burgoon, MP; Anderson, S; Hemmer, B; Stadelmann, C; Gattenlohner, S; Owens, GP; Gilden, D; Bennett, JL Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Neurology. 2010; 74(14):1127-1135 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Monson, NL; Brezinschek, HP; Brezinschek, RI; Mobley, A; Vaughan, GK; Frohman, EM; Racke, MK; Lipsky, PE Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients.
J NEUROIMMUNOL. 2005; 158(1-2): 170-181.
Web of Science PubMed FullText FullText_MUG

 

2004

Bartosik-Psujek, H; Archelos, JJ Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
J Neurol. 2004; 251(4):414-420
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Barkhof, F; Rocca, M; Francis, G; Van Waesberghe, JH; Uitdehaag, BM; Hommes, OR; Hartung, HP; Durelli, L; Edan, G; Fernández, O; Seeldrayers, P; Sørensen, P; Margrie, S; Rovaris, M; Comi, G; Filippi, M; Early Treatment of Multiple Sclerosis Study Group Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
Ann Neurol. 2003; 53(6):718-724
Web of Science PubMed FullText FullText_MUG

 

© Meduni Graz Impressum